PPBT

Purple BiotechC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Current thesis

Composite grade C from latest DB weights. Momentum 69.3 / Value 41.1

Posture

Mixed

Lead driver

Momentum

What changed

Momentum remains the lead driver in the composite.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

— · Net —

AI TargetsBase - · Bull - · Bear -

Data freshness

Prices

As of 2026-07-18

Fundamentals

As of 2026-07-17 • Vendor: Data Vendor v1

Scores

As of 2026-07-18 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-07-18

Supporting evidence

What

Grade C · Mixed

Confidence Medium · Net —

Target $30.00

Why

Momentum69 · Δ7d -

Value41 · Δ7d -0.1

SentimentN/A · Δ7d -

So what

Balanced signals. Wait for confirmation before sizing up.

Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits

Lead driver: Momentum · See technicals

Momentum

40% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

60% active weight

Current posture

7d trendFlat

Δ7d

-0.1

Δ21d

0.0

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade C. Momentum 69.3 / Value 41.1

Fundamentals (TTM)

As of 2026-07-17

Market Cap

$11.13M

Beta

-0.43

Shares Out

1.62M

P/E (TTM) · Derived

-0.1

P/S (TTM)

P/FCF (TTM) · Derived

-642.61

Rev YoY

EPS YoY

-94.1%

Gross Margin

+99.3%

Op Margin

Net Debt

-$9.33M

Current Ratio

1.48

As of 2026-07-18 • Updated nightlySource: Internal modelMethodology